000			01963 a2200565 4500
005			20250516220343.0
264		0	_c20150209
008			201502s 0 0 eng d
022			_a1432-1335
024	7		_a10.1007/s00432-014-1738-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aLitovkin, Kirill
245	0	0	_aMethylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer. _h[electronic resource]
260			_bJournal of cancer research and clinical oncology _cNov 2014
300			_a1849-61 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCarrier Proteins _xgenetics
650	0	4	_aCell Cycle Proteins
650	0	4	_aCell Line, Tumor
650	0	4	_aDNA Methylation
650	0	4	_aHomeodomain Proteins _xgenetics
650	0	4	_aHumans
650	0	4	_aKallikreins _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xblood
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aProportional Hazards Models
650	0	4	_aProstate-Specific Antigen _xblood
650	0	4	_aProstatic Hyperplasia _xgenetics
650	0	4	_aProstatic Neoplasms _xblood
650	0	4	_aTranscription Factors _xgenetics
650	0	4	_aTumor Suppressor Proteins _xgenetics
650	0	4	_aHomeobox Protein PITX2
700	1		_aJoniau, Steven
700	1		_aLerut, Evelyne
700	1		_aLaenen, Annouschka
700	1		_aGevaert, Olivier
700	1		_aSpahn, Martin
700	1		_aKneitz, Burkhard
700	1		_aIsebaert, Sofie
700	1		_aHaustermans, Karin
700	1		_aBeullens, Monique
700	1		_aVan Eynde, Aleyde
700	1		_aBollen, Mathieu
773	0		_tJournal of cancer research and clinical oncology _gvol. 140 _gno. 11 _gp. 1849-61
856	4	0	_uhttps://doi.org/10.1007/s00432-014-1738-8 _zAvailable from publisher's website
999			_c23927513 _d23927513